查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1977754

全球體外肺模型市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global In Vitro Lung Model Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 126 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

體外肺模型市場預計將從 2025 年的 4,925.2 億美元成長到 2034 年的 20.1725 億美元，2026 年至 2034 年的複合年成長率為 16.96%。

受呼吸系統疾病研發投入不斷增加的推動，全球體外肺模型市場正經歷強勁成長。體外肺模型為研究肺功能和測試治療性介入介入提供了一個基於實驗室的平台。對動物實驗替代方案日益成長的需求也促進了市場擴張。

呼吸系統疾病盛行率的上升和組織工程技術的進步是推動成長要素。製藥公司正在採用肺部模型來加快藥物篩檢和毒性測試。研究經費的增加和學術合作的加強進一步促進了市場成長。此外，3D細胞培養系統的技術創新也有助於提高模型的精確度。

隨著個人化醫療和精準藥物檢測的重要性日益凸顯，前景依然光明。新興市場對研發基礎設施的投資正在創造新的機會。各公司正致力於提升模型的真實性和擴充性。隨著全球呼吸系統研究的不斷深入，全球體外肺模型市場預計將穩定成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球體外肺模型市場：依類型分類

  • 市場分析、洞察與預測
  • 2D
  • 3D

第5章：全球體外肺模型市場：依應用分類

  • 市場分析、洞察與預測
  • 藥物篩檢
  • 毒理學
  • 3D模型開發
  • 基礎研究
  • 生理學研究
  • 幹細胞研究
  • 再生醫學

第6章：全球體外肺模型市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Mattek
    • Lonza
    • ATCC
    • InSphero
    • Emulate
    • AlveoliX AG
    • Mimetas US Inc
    • TissUse GmbH
    • Konica Minolta Business Solutions India Private Limited
    • Hologic Inc
    • Brainlab AG
    • Varian Medical Systems Inc
    • McKesson Corporation
    • MICA Information Systems Inc
    • Olympus Corporation
簡介目錄
Product Code: VMR112113159

The In Vitro Lung Model Market size is expected to reach USD 2017.25 Billion in 2034 from USD 492.52 Billion (2025) growing at a CAGR of 16.96% during 2026-2034.

The Global In Vitro Lung Model Market is witnessing strong growth driven by increasing research in respiratory diseases and drug development. In vitro lung models provide laboratory-based platforms to study lung function and test therapeutic interventions. Growing demand for alternatives to animal testing is supporting market expansion.

Major growth drivers include rising prevalence of respiratory disorders and advancements in tissue engineering technologies. Pharmaceutical companies are adopting lung models to accelerate drug screening and toxicity studies. Increasing research funding and academic collaborations are further strengthening market growth. Additionally, technological innovations in 3D cell culture systems are enhancing model accuracy.

Future prospects remain promising as personalized medicine and precision drug testing gain importance. Emerging markets investing in research infrastructure will create new opportunities. Companies are focusing on improving model realism and scalability. As respiratory research advances globally, the Global In Vitro Lung Model Market is expected to grow steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • 2D
  • 3D

By Application

  • Drug Screening
  • Toxicology
  • 3D Model Development
  • Basic Research
  • Physiologic Research
  • Stem Cell Research
  • Regenerative Medicine

COMPANIES PROFILED

  • Mattek, Lonza, ATCC, InSphero, Emulate, AlveoliX AG, Mimetas US Inc, TissUse GmbH, Konica Minolta Business Solutions India Private Limited, Hologic Inc, Brainlab AG, Varian Medical Systems Inc, McKesson Corporation, MICA Information Systems Inc, Olympus Corporation
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL IN VITRO LUNG MODEL MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. 2D Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. 3D Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IN VITRO LUNG MODEL MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Drug Screening Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Toxicology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. 3D Model Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Basic Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Physiologic Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Stem Cell Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.8. Regenerative Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IN VITRO LUNG MODEL MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Type
    • 6.2.2 By Application
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Type
    • 6.3.2 By Application
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Type
    • 6.4.2 By Application
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Type
    • 6.5.2 By Application
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Type
    • 6.6.2 By Application
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL IN VITRO LUNG MODEL INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Mattek
    • 8.2.2 Lonza
    • 8.2.3 ATCC
    • 8.2.4 InSphero
    • 8.2.5 Emulate
    • 8.2.6 AlveoliX AG
    • 8.2.7 Mimetas US Inc
    • 8.2.8 TissUse GmbH
    • 8.2.9 Konica Minolta Business Solutions India Private Limited
    • 8.2.10 Hologic Inc
    • 8.2.11 Brainlab AG
    • 8.2.12 Varian Medical Systems Inc
    • 8.2.13 McKesson Corporation
    • 8.2.14 MICA Information Systems Inc
    • 8.2.15 Olympus Corporation